JPMorgan issued a Neutral rating for CHINA RE due to its significant market share in the mainland China reinsurance market and better-than-expected combined ratios among global peers. However, the company has underperformed the market, falling 23% year to date. Structural factors, such as limited earnings momentum from its non-reinsurance segment and constraints in profit-sharing from domestic contracts, may hinder its valuation re-rating. Consequently, JPM lowered its target price from HKD1.6 to HKD1.4.
